Pfizer and Astellas report positive data from prostate cancer therapy trial

Pfizer and Astellas report positive data from prostate cancer therapy trial

Submitted by admin on March 17, 2023 - 10:02am
Source: 
Clinical Trials Arena
News Tags: 
Pfizer
Astellas
prostate cancer
clinical trials
Enzalutamide
leuprolide
Headline: 
Pfizer and Astellas report positive data from prostate cancer therapy trial
snippet: 

The trial evaluated enzalutamide, along with leuprolide, in non-metastatic, hormone-sensitive prostate cancer patients.

Do Not Allow Advertisers to Use My Personal information